ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 27 filers reported holding ADMA BIOLOGICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $90,000 | -10.0% | 22,500 | 0.0% | 0.01% | -15.4% |
| Q3 2019 | $100,000 | -40.5% | 22,500 | -39.9% | 0.01% | +30.0% |
| Q2 2018 | $168,000 | +64.7% | 37,460 | +68.7% | 0.01% | +42.9% |
| Q1 2018 | $102,000 | +161.5% | 22,200 | +107.5% | 0.01% | +250.0% |
| Q2 2017 | $39,000 | -57.1% | 10,700 | -43.0% | 0.00% | -66.7% |
| Q1 2017 | $91,000 | +33.8% | 18,787 | +40.4% | 0.01% | 0.0% |
| Q4 2016 | $68,000 | -75.9% | 13,380 | -65.7% | 0.01% | -73.9% |
| Q3 2016 | $282,000 | +51.6% | 39,000 | +24.6% | 0.02% | +35.3% |
| Q2 2016 | $186,000 | +67.6% | 31,300 | +126.8% | 0.02% | +54.5% |
| Q1 2016 | $111,000 | +26.1% | 13,800 | +25.5% | 0.01% | 0.0% |
| Q4 2015 | $88,000 | -14.6% | 11,000 | -1.8% | 0.01% | -21.4% |
| Q2 2015 | $103,000 | -21.4% | 11,200 | -18.8% | 0.01% | -22.2% |
| Q1 2015 | $131,000 | – | 13,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |